Authors: Cappoli, Natalia
Mezzogori, Daniele
Tabolacci, Elisabetta
Coletta, Isabella
Navarra, Pierluigi
Pani, Giovambattista
Dello Russo, Cinzia
Title: The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells
Language (ISO): en
Abstract: Emerging evidence suggests the potential use of rapamycin in treatment of several neurological disorders. The drug readily crosses the blood brain barrier and may exert direct immunomodulatory effects within the brain. Microglia are the main innate immune cells of the brain, thus critically involved in the initiation and development of inflammatory processes at this level. However, there are conflicting data from rodent studies about the pharmacological effects of rapamycin on microglial inflammatory responses. Considering that rodent microglia display relevant biochemical and harmacological differences compared to human microglia, in the present study we studied the effects of rapamycin in an experimental model of human microglia, the human microglial clone 3 (HMC3) cell line. Rapamycin was tested in the nM range both under basal conditions and in cells activated with a pro-nflammatory cytokine cocktail, consisting in a mixture of interferon-γ and interleukin-1β (II). The drug significantly increased II stimulatory effect on interleukin-6 (IL-6) expression and release in the HMC3 cells, while reducing the production of free oxygen radicals (ROS) both under basal conditions and in cells activated with II. Consistently with its known molecular mechanism of action, rapamycin reduced the extent of activation of the so-called ‘mechanistic’ target of rapamycin complex 1 (mTORC1) kinase and the total amount of intracellular proteins. In contrast to rodent cells, rapamycin did not alter human microglial cell viability nor inhibited cell proliferation. Moreover, rapamycin did not exert any significant effect on the morphology of the HMC3 cells. All together these data suggest that the inhibition of mTORC1 in human microglia by rapamycin results in complex immunomodulatory effects, including a significant increase in the expression and release of the pro-inflammatory IL-6.
Subject Headings: HMC3 microglial cells
Rapamycin
IL-6
ROS
Pro-inflammatory cytokines
URI: http://hdl.handle.net/2003/39048
http://dx.doi.org/10.17877/DE290R-20967
Issue Date: 2019-09-06
Rights link: http://creativecommons.org/licenses/by/4.0/
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Dello_Russo_06092019_proof.pdfDNB722.79 kBAdobe PDFView/Open
Dello_Russo_06092019_supplementary_material.pdfDNB28.3 kBAdobe PDFView/Open


This item is protected by original copyright



All resources in the repository are protected by copyright.